06May/13

Organ donation 'still worth it' – Herald Sun

Organ donation ‘still worth it’
Herald Sun
“Potential donors and their families and potential recipients and their families have no reason not to have confidence in organ donation and transplant procedures.” Ms Jamieson recommended that the DonateLife Organization be authorised by hospitals to
Organ donation facts – Reading EagleReading Eagle
Keep faith in donor system: Vic coroner – NinemsnNinemsn
Mouse virus blamed for organ transplant deaths – The AgeThe Age
Yahoo!7 News
all 8 news articles »
06May/13

Millions Have Chronic Kidney Disease But Don't Know It, Study Finds – Everyday Health


Sun News Network

Millions Have Chronic Kidney Disease But Don’t Know It, Study Finds
Everyday Health
MONDAY, May 6, 2013 — Millions of people in Canada are unaware that they have chronic kidney disease, even when it progresses into the later stages, according to a study published today in the Canadian Medical Association Journal. Researchers found
Prevalence estimates of chronic kidney disease in Canada: results of a CMAJ
Kidney disease in Canada: 12.5 percent of adults afflicted, yet many unawareEurekAlert (press release)
Nearly 3 million Canadians have kidney disease, and few know it: StudyToronto Sun

all 7 news articles »

06May/13

New Antiviral Treatment Could Significantly Reduce Global Burden of Hepatitis C – Science Daily (press release)

New Antiviral Treatment Could Significantly Reduce Global Burden of Hepatitis C
Science Daily (press release)
May 6, 2013 — Around 150 million people globally are chronically infected with the hepatitis C virus (HCV) — a major cause of liver disease and the fastest growing cause of liver transplantation and liver cancer.1 New prevention strategies are
New Hepatitis C Treatment Offers 90% Cure, May Halve Infection Rate In Medical Daily

all 2 news articles »

06May/13

Medtronic gets FDA approval for heart-failure device – Minneapolis / St. Paul Business Journal (blog)


Medgadget.com

Medtronic gets FDA approval for heart-failure device
Minneapolis / St. Paul Business Journal (blog)
Medtronic Inc. has won regulatory approval to sell its Viva cardiac device, which targets patients suffering from heart failure, the company announced Monday. Patients treated with the Viva resynchronization device experienced 21 percent fewer
Medtronic Announces FDA Approval of New Portfolio of Next – Gen Cardiac MarketWatch
Medtronic’s Viva Wins US Approval to Resynchronize Heart (2)Businessweek
Medtronic’s new device sparks war of words with Boston ScientificMinneapolis Star Tribune

all 7 news articles »